Amphastar Pharmaceuticals, Inc. AMPH
Set alert
27.03 USD -0.69 -2.49%
At close · Nov 2
27.03 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
26.69 Day range 27.72
16.65 52-week range 29.52
- YTD
- +0.93%
- 1 year
- +6.00%
- Open
- 27.72
- Prev close
- 27.72
- Mkt cap
- 1.15B
- Vol
- 497.70K
- Avg vol
- 465.99K
- EPS
- 1.65
- P/E
- 16.38
- Div yield
- 0.00%
More statistics
- Low
- 26.69
- High
- 27.72
- Forward P/E
- 8.52
- Beta
- 0.94
- Short ratio
- 8.22
- Inst. own
- 68.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 24.76
- 200-d avg
- 22.25
- 1y target
- 22.50
5m chart
Built from the cached five-day intraday bars.
Signals (108)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:50 PM | 3 days ago |
| RSI: Overbought | Oct 30, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 30, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:50 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
Newest 20 of 108.
Financial health
Altman Z-Score
2.19 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 1
- P/E 3
- P/B 4
Valuation
P/E 12.8×
FY 2016 5y median 14.9× FY 2025
P/S 1.7×
FY 2016 5y median 2.5× FY 2025
P/B 1.6×
FY 2016 5y median 2.5× FY 2025
P/FCF 10.3×
FY 2016 5y median 15.8× FY 2025
EV/EBITDA 8.2×
FY 2016 5y median 8.9× FY 2025
EV/Sales 2.4×
FY 2016 5y median 2.6× FY 2025
FCF Yield 9.7%
FY 2016 5y median 6.3% FY 2025
Profitability
Gross Margin 49.5%
FY 2016 5y median 49.9% FY 2025
Operating Margin 19.5%
FY 2016 5y median 21.5% FY 2025
Net Margin 13.6%
FY 2016 5y median 18.3% FY 2025
ROE 12.4%
FY 2016 5y median 17.3% FY 2025
ROIC 7.5%
FY 2016 5y median 12.3% FY 2025
ROA 6.0%
FY 2016 5y median 9.2% FY 2025
Growth (YoY)
Revenue -1.7%
FY 2016 FY 2025
Operating Income -31.7%
FY 2016 FY 2025
EPS (diluted) -33.7%
FY 2016 FY 2025
Free Cash Flow -29.7%
FY 2016 FY 2025
Financial Health
Current Ratio 4.0×
FY 2016 5y median 3.1× FY 2025
Quick Ratio 2.9×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.8×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 2.3×
FY 2016 5y median 1.8× FY 2025
Interest Coverage 5.5×
FY 2016 5y median 7.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
